Literature DB >> 26678403

The Evolving Profile of the Signature Amino Acid Residues in HIV-1 Subtype C Tat.

Shambhu Prasad G Aralaguppe1, Shilpee Sharma1, Malini Menon1, Vinayaka R Prasad2, Shanmugam Saravanan3, Kailapuri G Murugavel3, Suniti Solomon3, Udaykumar Ranga1.   

Abstract

Using several HIV-1 tat exon 1 amino acid sequences available from public databases and additional sequences derived from a southern Indian clinical cohort, we compared the profile of the signature amino acid residues (SAR) between two different time periods, 1986-2004 and 2005-2014. The analysis identified eight positions as signature residues in subtype C Tat and demonstrated a changing pattern at four of these positions between the two periods. At three locations (histidine 29, serine 57, and proline 60), there appears to be a nonuniform negative selection against the SAR. The negative selection appears to be severe, especially against histidine 29 (p < .0001) and moderate against proline 60 (p < .0001). The negative selection against serine 57 is statistically insignificant and appears to have begun recently. At position 63, the frequency of signature residue glutamic acid increased over the past decade, although the difference was not significant. Importantly, at the three locations where the negative selection is in progress, the substitute amino acids are the generic residues present in most of the other HIV-1 subtypes. Our data demonstrate that viral evolution can subject specific amino acid residues to subtle and progressive selection pressures without affecting the prevalence of other amino acid residues.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26678403      PMCID: PMC5912721          DOI: 10.1089/AID.2015.0208

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  42 in total

1.  HIV-1 Tat interactions with p300 and PCAF transcriptional coactivators inhibit histone acetylation and neurotrophin signaling through CREB.

Authors:  Kasuen Wong; Anima Sharma; Soumya Awasthi; Elizabeth F Matlock; Lowery Rogers; Carine Van Lint; Daniel J Skiest; Dennis K Burns; Robert Harrod
Journal:  J Biol Chem       Date:  2004-12-15       Impact factor: 5.157

Review 2.  HIV-I Tat: a polypeptide for all seasons.

Authors:  A Rubartelli; A Poggi; R Sitia; M R Zocchi
Journal:  Immunol Today       Date:  1998-12

3.  HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim.

Authors:  Dan Chen; Michael Wang; Sharleen Zhou; Qiang Zhou
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

4.  A computer program designed to screen rapidly for HIV type 1 intersubtype recombinant sequences.

Authors:  A C Siepel; A L Halpern; C Macken; B T Korber
Journal:  AIDS Res Hum Retroviruses       Date:  1995-11       Impact factor: 2.205

5.  A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1.

Authors:  F Gao; D L Robertson; C D Carruthers; S G Morrison; B Jian; Y Chen; F Barré-Sinoussi; M Girard; A Srinivasan; A G Abimiku; G M Shaw; P M Sharp; B H Hahn
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

6.  The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence.

Authors:  G Barillari; R Gendelman; R C Gallo; B Ensoli
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

7.  Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif.

Authors:  Mamata Mishra; S Vetrivel; Nagadenahalli B Siddappa; Udaykumar Ranga; Pankaj Seth
Journal:  Ann Neurol       Date:  2008-03       Impact factor: 10.422

8.  Thioredoxin reductase-1 negatively regulates HIV-1 transactivating protein Tat-dependent transcription in human macrophages.

Authors:  Parisa Kalantari; Vivek Narayan; Sathish K Natarajan; Kambadur Muralidhar; Ujjawal H Gandhi; Hema Vunta; Andrew J Henderson; K Sandeep Prabhu
Journal:  J Biol Chem       Date:  2008-10-03       Impact factor: 5.157

9.  Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence.

Authors:  Vasudev R Rao; Ujjwal Neogi; Joshua S Talboom; Ligia Padilla; Mustafizur Rahman; Cari Fritz-French; Sandra Gonzalez-Ramirez; Anjali Verma; Charles Wood; Ruth M Ruprecht; Udaykumar Ranga; Tasnim Azim; John Joska; Eliseo Eugenin; Anita Shet; Heather Bimonte-Nelson; William R Tyor; Vinayaka R Prasad
Journal:  Retrovirology       Date:  2013-06-08       Impact factor: 4.602

10.  Effect on HIV-1 gene expression, Tat-Vpr interaction and cell apoptosis by natural variants of HIV-1 Tat exon 1 and Vpr from Northern India.

Authors:  Sneh Lata; Larance Ronsard; Vikas Sood; Sajad A Dar; Vishnampettai G Ramachandran; Shukla Das; Akhil C Banerjea
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

View more
  1 in total

1.  Origin and evolution of HIV-1 subtype A6.

Authors:  Syed Hani Abidi; Lazzat Aibekova; Salima Davlidova; Aidana Amangeldiyeva; Brian Foley; Syed Ali
Journal:  PLoS One       Date:  2021-12-13       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.